Newsroom
Keep in touch
Join our mailing list to receive new information relating to biomarker discovery and detection.
Webinar: 180x Signal Boost in Cardiac Troponin I ELISA
02/12/2025Webinar: BOLD Amplification of IL-4 ELISA
07/05/2025Exazym®: New Detection Limits Open New Possibilities
26/09/2024Exazym® — Pixels to Proteins
26/09/2024Exazym® — Ultra-Sensitivity Meets Practicality
26/09/2024Exazym® — A Breakthrough in Precision Health
26/09/2024
Now, attomole-level detection of low-abundance biomarkers using standard ELISA workflows
02/04/2024 Continue reading
Pioneering the Future of Healthcare: Cavidi's BOLD Role in Harnessing the Power of Rare Biomarkers
22/01/2024 Continue reading
Cavidi launches novel platform technology - Exazym®
17/05/2021To showcase of the potential utility of Exazym®, we have demon...
Continue readingNordic Collaboration for SARS-CoV-2 virology and serology testing
13/07/2020Nordic virus monitoring and diagnostics’ companies Cavidi and ...
Continue reading
Olof Larsson joins Cavidi as R&D Director
09/04/2020Olof has an academic background with a Ph.D. Pharmacology and a ...
Continue reading
COVID-19 and HIV how we can learn from pandemics
30/03/2020In times of uncertainty and crisis, clear information saves live...
Continue reading
Walter Campos MBA, MSc, PhD Virology has been promoted to Commercial Director, Africa
05/03/2020Walter Campos MBA, MSc, PhD Virology has been promoted to Commer...
Continue reading
Cavidi secures ALMI grant to expand presence in US market
22/05/2018The gene therapy market in the United States is growing rapidly,...
Continue reading